/Cas9:CAR-T

Wei Wei1, Zhi-Nan Chen1, Ke Wang1

  • 1National Translational Science Center for Molecular Medicine & Department of Cell Biology, Fourth Military Medical University, Xi'an 710032, China.

概括

化学抗原受体T (CAR-T) 细胞疗法对癌症有希望,但在持久性方面面临挑战. 克里斯普尔/Cas9技术增强了CAR-T细胞的增殖和寿命,改善了抗瘤潜力,以获得更好的癌症治疗结果.